All In Biotech

Drug Trial Radar · NCT07881965

A Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia

A Multicenter, Open-label Phase IIIb Clinical Study to Evaluate the Long-term Safety and Efficacy of WS016 in Patients With Hyperkalemia

Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Sep 25, 2026

Primary completion

Feb 20, 2029

Study completion Mar 30, 2029

Sponsor

Sponsor type
Industry
First posted
Oct 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is an open-label, consisting of 2 phases, corrective phase (CP) and a maintenance phase (MP). The corrective phase aims to correct hyperkalemia within 24 to 72 hours, the maintenance phase aims to maintain the serum potassium level of subjects in the normal range for 12-month extension study carried out in participants who come from the first phase and meet certain inclusion criteria.

Conditions

  • Hyperkalemia

Interventions

  • WS016Drug

    There is no other interventions in this clinical study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of subjects with the mean serum potassium ≤5.0 mmol/L during maintenance phaseTime frame: Maintenance phase 12-month

Locations

50 sites in 1 country. Site status is shown where the registry gives one.

  • Investigator Site 01

    Beijing, China · Recruiting

  • Investigator Site 20

    Anqing, Anhui, China · Not yet recruiting

  • Investigator Site 18

    Hefei, Anhui, China · Not yet recruiting

  • Investigator Site 19

    Wuhu, Anhui, China · Recruiting

  • Investigator Site 42

    Xuancheng, Anhui, China · Not yet recruiting

  • Investigator Site 50

    Beijing, Beijing Municipality, China · Recruiting

  • Investigator Site 44

    Xiamen, Fujian, China · Not yet recruiting

  • Investigator Site 45

    Lanzhou, Gansu, China · Not yet recruiting

  • Investigator Site 22

    Guangzhou, Guangdong, China · Recruiting

  • Investigator Site 23

    Shantou, Guangdong, China · Not yet recruiting

  • Investigator Site 21

    Zhanjiang, Guangdong, China · Not yet recruiting

  • Investigator Site 35

    Guiyang, Guizhou, China · Not yet recruiting

  • Investigator Site 02

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Investigator Site 03

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Investigator Site 04

    Luoyang, Henan, China · Not yet recruiting

  • Investigator Site 06

    Nanyang, Henan, China · Not yet recruiting

  • Investigator Site 07

    Puyang, Henan, China · Not yet recruiting

  • Investigator Site 41

    Sanmenxia, Henan, China · Recruiting

  • Investigator Site 05

    Xinxiang, Henan, China · Not yet recruiting

  • Investigator Site 26

    Huangshi, Hubei, China · Recruiting

  • Investigator Site 48

    Jingzhou, Hubei, China · Not yet recruiting

  • Investigator Site 27

    Shiyan, Hubei, China · Not yet recruiting

  • Investigator Site 24

    Wuhan, Hubei, China · Recruiting

  • Investigator Site 25

    Wuhan, Hubei, China · Not yet recruiting

  • Investigator Site 30

    Zhuzhou, Hunan, China · Recruiting

  • Investigator Site 37

    Hohhot, Inner Mongolia, China · Not yet recruiting

  • Investigator Site 10

    Nanjing, Jiangsu, China · Recruiting

  • Investigator Site 11

    Nanjing, Jiangsu, China · Recruiting

  • Investigator Site 14

    Nantong, Jiangsu, China · Not yet recruiting

  • Investigator Site 12

    Suzhou, Jiangsu, China · Not yet recruiting

  • Investigator Site 13

    Yangzhou, Jiangsu, China · Not yet recruiting

  • Investigator Site 29

    Ganzhou, Jiangxi, China · Not yet recruiting

  • Investigator Site 28

    Nanchang, Jiangxi, China · Not yet recruiting

  • Investigator Site 49

    Pingxiang, Jiangxi, China · Not yet recruiting

  • Investigator Site 38

    Shenyang, Liaoning, China · Recruiting

  • Investigator Site 36

    Yinchuan, Ningxia, China · Not yet recruiting

  • Investigator Site 39

    Tai’an, Shandong, China · Not yet recruiting

  • Investigator Site 08

    Tancheng, Shandong, China · Recruiting

  • Investigator Site 40

    Weifang, Shandong, China · Not yet recruiting

  • Investigator Site 09

    Shanghai, Shanghai Municipality, China · Not yet recruiting

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.